Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 5.11 -0.58% -0.03
EIGR closed down 0.58 percent on Monday, March 18, 2024, on 1.8 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -0.58%
Earnings Movers Other -0.58%
Wide Bands Range Expansion -0.58%

   Recent Intraday Alerts

Alert Time
Up 5% about 9 hours ago
Up 3% about 9 hours ago
Up 2% about 9 hours ago
Possible NR7 about 10 hours ago
Possible Inside Day about 10 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Hypertension Hepatitis Specialty Drugs Pulmonary Arterial Hypertension Orphan Disease Pulmonary Hypertension Treatment Of Hepatitis Lymphedema Hypoglycemia

Is EIGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.35
52 Week Low 5.1
Average Volume 8,449
200-Day Moving Average 13.66
50-Day Moving Average 6.29
20-Day Moving Average 6.05
10-Day Moving Average 6.21
Average True Range 0.70
RSI (14) 37.89
ADX 23.24
+DI 17.28
-DI 21.06
Chandelier Exit (Long, 3 ATRs) 6.15
Chandelier Exit (Short, 3 ATRs) 7.21
Upper Bollinger Bands 7.32
Lower Bollinger Band 4.78
Percent B (%b) 0.13
BandWidth 42.06
MACD Line -0.19
MACD Signal Line -0.06
MACD Histogram -0.13
Fundamentals Value
Market Cap 7.56 Million
Num Shares 1.48 Million
EPS -58.50
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 0.62
Price-to-Book 0.87
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.63
Resistance 3 (R3) 5.69 5.57 5.55
Resistance 2 (R2) 5.57 5.43 5.54 5.52
Resistance 1 (R1) 5.34 5.35 5.28 5.28 5.49
Pivot Point 5.22 5.22 5.19 5.19 5.22
Support 1 (S1) 4.99 5.09 4.93 4.94 4.73
Support 2 (S2) 4.87 5.00 4.84 4.70
Support 3 (S3) 4.64 4.87 4.68
Support 4 (S4) 4.59